Breeman WA - Search Results

1

Anticancer activity of targeted proapoptotic peptides.

Capello A, Krenning EP, Bernard BF, Breeman WA, Erion JL, de Jong M. Capello A, et al. Among authors: breeman wa. J Nucl Med. 2006 Jan;47(1):122-9. J Nucl Med. 2006. PMID: 16391196 Free article.

2

Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy.

Bernard B, Capello A, van Hagen M, Breeman W, Srinivasan A, Schmidt M, Erion J, van Gameren A, Krenning E, de Jong M. Bernard B, et al. Cancer Biother Radiopharm. 2004 Apr;19(2):173-80. doi: 10.1089/108497804323071940. Cancer Biother Radiopharm. 2004. PMID: 15186597

3

111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.

Capello A, Krenning E, Bernard B, Reubi JC, Breeman W, de Jong M. Capello A, et al. Eur J Nucl Med Mol Imaging. 2005 Nov;32(11):1288-95. doi: 10.1007/s00259-005-1877-x. Epub 2005 Jul 15. Eur J Nucl Med Mol Imaging. 2005. PMID: 16021448

4

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

De Jong M, Valkema R, Jamar F, Kvols LK, Kwekkeboom DJ, Breeman WA, Bakker WH, Smith C, Pauwels S, Krenning EP. De Jong M, et al. Among authors: breeman wa. Semin Nucl Med. 2002 Apr;32(2):133-40. doi: 10.1053/snuc.2002.31027. Semin Nucl Med. 2002. PMID: 11965608 Review.

5

Peptide receptor radionuclide therapy in vitro using [111In-DTPA0]octreotide.

Capello A, Krenning EP, Breeman WA, Bernard BF, de Jong M. Capello A, et al. Among authors: breeman wa. J Nucl Med. 2003 Jan;44(1):98-104. J Nucl Med. 2003. PMID: 12515882 Free article.

6

Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.

Hofland LJ, Lamberts SW, van Hagen PM, Reubi JC, Schaeffer J, Waaijers M, van Koetsveld PM, Srinivasan A, Krenning EP, Breeman WA. Hofland LJ, et al. Among authors: breeman wa. J Nucl Med. 2003 Aug;44(8):1315-21. J Nucl Med. 2003. PMID: 12902423 Free article.

7

Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog.

Capello A, Krenning EP, Bernard BF, Breeman WA, van Hagen MP, de Jong M. Capello A, et al. Among authors: breeman wa. J Nucl Med. 2004 Oct;45(10):1716-20. J Nucl Med. 2004. PMID: 15471839 Free article.

8

Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.

de Jong M, Breeman WA, Valkema R, Bernard BF, Krenning EP. de Jong M, et al. Among authors: breeman wa. J Nucl Med. 2005 Jan;46 Suppl 1:13S-7S. J Nucl Med. 2005. PMID: 15653647 Free article.

9

Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.

Fröberg AC, de Jong M, Nock BA, Breeman WA, Erion JL, Maina T, Verdijsseldonck M, de Herder WW, van der Lugt A, Kooij PP, Krenning EP. Fröberg AC, et al. Among authors: breeman wa. Eur J Nucl Med Mol Imaging. 2009 Aug;36(8):1265-72. doi: 10.1007/s00259-009-1098-9. Epub 2009 Mar 6. Eur J Nucl Med Mol Imaging. 2009. PMID: 19266197 Free PMC article.

10

Somatostatin receptor gene therapy combined with targeted therapy with radiolabeled octreotide: a new treatment for liver metastases.

Mearadji A, Breeman W, Hofland L, van Koetsveld P, Marquet R, Jeekel J, Krenning E, van Eijck C. Mearadji A, et al. Ann Surg. 2002 Dec;236(6):722-8; discussion 728-9. doi: 10.1097/00000658-200212000-00004. Ann Surg. 2002. PMID: 12454510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters